LRRK2 and Parkinson disease: Emerging evidence indicates that mitochondrial dysfunction represents a central pathogenic feature of PD, integrating the impact of genetic mutations such as PINK1, PRKN, and LRRK2 and environmental exposure to neurotoxins such as Rotenone and MPTP.